Metabolic Control and Determinants Among HIV-Infected Type 2 Diabetes Mellitus Patients Attending a Tertiary Clinic in Botswana.
Godfrey Mutashambara RwegereraDorothea H P ShailemoYordanka Pina RiveraKathryn O MokgosiPortia BaleTaibat Aderonke OyewoBruno Diaz LuisDereje HabteBrian B GodmanPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)
Metabolic syndrome is an appreciable problem in this tertiary clinic in Botswana for both HIV-infected and HIV-negative participants. Future prospective studies are warranted in our setting and similar sub-Saharan settings to enhance understanding of the role played by HAART in causing the metabolic syndrome, and the implications for future patient management.
Keyphrases
- hiv infected
- antiretroviral therapy
- metabolic syndrome
- human immunodeficiency virus
- hiv infected patients
- end stage renal disease
- hiv positive
- primary care
- current status
- newly diagnosed
- ejection fraction
- uric acid
- chronic kidney disease
- cardiovascular risk factors
- prognostic factors
- case report
- peritoneal dialysis
- cardiovascular disease
- patient reported outcomes
- adipose tissue
- skeletal muscle
- hiv testing
- weight loss